Results 191 to 200 of about 292,602 (219)

The CARL II cohort: what we did and what came out of it. [PDF]

Chiropr Man Therap
Hartvigsen J, Aspinall S, Downie A, Harsted S, Jenkins H, Marchand AA, McNaughton D, Miller A, Nim C, Nyirö L, Roseen EJ, Young JJ, Weber KA, Wong JJ, Øverås CK, Diana De Carvalho, Adams J.   +16 more
europepmc   +1 more source

Outcomes and future activities of the 'Pan-European network in Lipidomics and EpiLipidomics - EpiLipidNET'. [PDF]

Metabolomics
Kuligowski J, Bertrand-Michel J, Cazenave-Gassiot A, Goracci L, Domingues P, Orešič M, Thorsteinsdottir M, Gruber F, Willighagen EL, Spickett CM, Ruskovska T, O'Donnell VB, Prabutzki P, Petrović S, Godzien J, Tortorella S, Reis A, Dias IHK, Schleyer G, Domingues R, Fedorova M.   +20 more
europepmc   +1 more source

Industry Interactions at Medical Conferences: Representatives' Credentials and the Disclosure of Data Limitations Influence Clinician Perceptions. [PDF]

J Am Board Fam Med
O'Donoghue AC, Aikin KJ, Amoozegar JB, Johnson M, Adewumi I, Rupert DJ.   +5 more
europepmc   +1 more source

Youth in global environmental negotiations: The YouthEarth dataset. [PDF]

Data Brief
Vergonjeanne A, Orsini A.
europepmc   +1 more source

Visa restrictions: A structural determinant of global health that must be confronted head-on. [PDF]

PLOS Glob Public Health
Bain LE, Ojong SA, Sindi JK, Njei B, Omam LA, Kyobutungi C.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

One-third of Indian STEM conferences have no women

Nature, 2023
Dyani Lewis
exaly